NCT00188071

Brief Summary

  • To compare postoperative analgesia by paracetamol 1gr or ketoprofen 100 mg or the combination of these two analgesics
  • each treatment beeing allocated by randomization

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2002

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2002

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2003

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
Last Updated

November 1, 2017

Status Verified

September 1, 2005

First QC Date

September 12, 2005

Last Update Submit

October 30, 2017

Conditions

Keywords

medical abortionanalgesia

Outcome Measures

Primary Outcomes (1)

  • postoperative pain rating

Secondary Outcomes (2)

  • morphine consumption

  • patient satisfaction

Interventions

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant women
  • medical abortion performed in day case surgery under local anesthesia
  • informed written consent

You may not qualify if:

  • under 18 year old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept of Anesthesia - CHU

Angers, 49933, France

Location

MeSH Terms

Conditions

Agnosia

Interventions

AcetaminophenKetoprofen

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylpropionatesAcids, CarbocyclicCarboxylic Acids

Study Officials

  • Jean Claude Granry, MD

    University hospital, Angers, FRANCE

    STUDY CHAIR
  • Emmanuel Mucci, MD

    University hospital, Angers, FRANCE

    PRINCIPAL INVESTIGATOR
  • Christine Monrigal, MD

    Dept of Anesthesia, CHU, Angers - France

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 16, 2005

Study Start

September 1, 2002

Study Completion

August 1, 2003

Last Updated

November 1, 2017

Record last verified: 2005-09

Locations